Government and PBMs can pursue penalties for noncompliance.
Using Blockchain technology, the new program will legally redispense expensive medications to those who cannot afford them.
Health systems employ Artifical Intelligence and integrated medication management to address diversion.
As robotics and other systems improve, the physical aspect of pharmacy dispensing is bound to change how pharmacists do their job.
In October 2016 Mylan N.V. announced that its subsidiary, Mylan Inc., agreed to pay a $465 million settlement to the U.S. Department of Justice (DOJ) to resolve questions surrounding the classification of EpiPen Auto-Injector and EpiPen Jr Auto-Injector (EpiPen) for the Medicaid Drug Rebate Program.